Zenith Healthcare Ltd (BSE: 530665) is a Ahmedabad, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹17 Cr, it ranks #4,736 by market cap among the 6,137 Indian listed companies on FinBizNet, and #23 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹3.07 (as of 25 Oct 2026), the share price is 55.3% below its 52-week high of ₹6.87 and 26.9% above its 52-week low of ₹2.42. The share price is down 24.5% over one year and up 3.8% over three months.
| Current Price | ₹3.07 |
|---|---|
| Market Cap | ₹17 Cr |
| BSE Code | 530665 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | 3,070 |
| Return on Equity | 0.13% |
| Return on Assets | -1.98% |
| 52-Week Range | ₹2.42 – ₹6.87 |
| 1-Year Price Change | -24.5% |
| 3-Month Price Change | +3.8% |
| Beta (1Y) | 0.42 |
| Headquarters | Ahmedabad, Gujarat |
| Website | www.zenithhealthcare.com |
| Revenue | ₹3 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 4.1% |
| EPS (Basic) | ₹0.03 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Zenith Healthcare Limited manufactures and markets pharmaceutical formulations in India. It offers its products in the form of tablets, capsules, oral liquids, and injectable. The company also engages in the contract manufacturing of various dosage forms. It supplies medicines to Cambodia, Myanmar, Papa New Guinea, Sri Lanka, Kenya, Nigeria, Gambia, Zambia, Namibia, Botswana, Armenia, Georgia, Uzbekistan, Paraguay, Bolivia, Venezuela, Guatemala, Barbados, Jamaica, Bahamas, Yemen, and Turkey. Zenith Healthcare Limited was incorporated in 1994 and is based in Ahmedabad, India.
1. Manufacturing of Pharmaceutical Formulations-This segment manufactures pharmaceutical formulations in the forms of tablets, capsules, oral liquid, and injectables.
1. Manufacture and Marketing of Pharmaceutical Formulations-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,73,448 Cr | 71.2 | 16.98% | ₹4,979 Cr | +28.0% |
| Aether Industries Limited | ₹20,419 Cr | 92.1 | 9.81% | ₹327 Cr | +88.8% |
| Alivus Life Sciences Ltd | ₹16,073 Cr | 27.7 | 18.36% | ₹640 Cr | +33.8% |
| Aarti Pharmalabs Ltd | ₹7,922 Cr | 43.2 | 8.49% | ₹536 Cr | -4.1% |
| Solara Active Pharma Sciences Limited | ₹3,361 Cr | -382.6 | -0.63% | ₹417 Cr | +3.3% |
| Sai Parenteral's Limited | ₹2,153 Cr | 110.9 | 2.88% | ₹179 Cr | — |
| KRM Ayurveda Limited | ₹556 Cr | 25.9 | — | ₹32 Cr | — |
| Trident Lifeline Limited | ₹501 Cr | 24.8 | — | — | +39.4% |
| Zenith Healthcare Ltd | ₹17 Cr | 3,070 | 0.13% | ₹3 Cr | -24.5% |
Listed by market capitalisation. Ratios are shown for context only.
Zenith Healthcare Ltd is trading at ₹3.07, with a market capitalisation of ₹17 Cr.
Zenith Healthcare Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Zenith Healthcare Ltd has a P/E of 3,070 and a return on equity of 0.13%.
Zenith Healthcare Ltd is listed on the BSE under the scrip code 530665.
Zenith Healthcare Ltd's share price is down 24.5% over one year and up 3.8% over three months. Its 52-week range is ₹2.42 to ₹6.87.
In Q1 FY27, Zenith Healthcare Ltd reported revenue of ₹3 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.03 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.